FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W85679339> ?p ?o ?g. }

• W85679339 endingPage "16" @default.
• W85679339 startingPage "3107" @default.
• W85679339 abstract "The work from numerous laboratories has led to the idea that the growth factors such as platelet-derived growth factor (PDGF) contribute to proliferative vitreoretinopathy (PVR) in experimental models of the disease, as well as in humans. In support of this idea, the authors have previously reported that cells unable to respond to PDGF had a greatly reduced PVR potential, compared with PDGF-responsive versions of the same cells. The goal of this study was to test the effect of blocking the output of the PDGF receptor in an experimental model of PVR.Polymerase chain reaction-based site-directed mutagenesis was used to generate point mutations in the human PDGF alpha receptor (alphaPDGFR) cDNA, which resulted in single amino acid substitutions. These changes were based on naturally occurring point mutations in the c-kit receptor tyrosine kinase, which suppresses the function of wild-type c-kit. A truncated alphaPDGFR was also made, in which the receptor ended just after the juxtamembrane domain. As with the point mutants, truncated receptors have been shown to block the action of wild-type receptors. All the alphaPDGFR mutants were introduced into cells that naturally express the wild-type receptor, and the PDGF-dependent output of the resultant cell lines was determined. In addition, the PVR potential of cell lines expressing the mutant receptors was tested in a PVR rabbit model.Although the mutants differed in their ability to suppress PDGF-dependent signaling of the wild-type receptor, each mutant effectively blocked cell cycle progression. When expressed in rabbit conjunctival fibroblasts, a cell line that effectively induces PVR, the mutant receptors blocked PVR to various degrees. The most effective receptor was the truncated mutant.These data suggest that the alphaPDGFR plays an important role in PVR. In addition, these mutant receptors appear to have therapeutic potential for prevention of this blinding disease." @default.
• W85679339 created "2016-06-24" @default.
• W85679339 creator A5071301207 @default.
• W85679339 creator A5084984241 @default.
• W85679339 creator A5087393717 @default.
• W85679339 date "2000-09-01" @default.
• W85679339 modified "2023-10-17" @default.
• W85679339 title "Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor." @default.
• W85679339 cites W1479859897 @default.
• W85679339 cites W1492896001 @default.
• W85679339 cites W1512958442 @default.
• W85679339 cites W1514031343 @default.
• W85679339 cites W1536784471 @default.
• W85679339 cites W1608832822 @default.
• W85679339 cites W1673016819 @default.
• W85679339 cites W1725436419 @default.
• W85679339 cites W1836215938 @default.
• W85679339 cites W1920142430 @default.
• W85679339 cites W1964822816 @default.
• W85679339 cites W19734096 @default.
• W85679339 cites W1977861466 @default.
• W85679339 cites W1978857678 @default.
• W85679339 cites W1981970388 @default.
• W85679339 cites W1982270903 @default.
• W85679339 cites W1988295822 @default.
• W85679339 cites W1995125071 @default.
• W85679339 cites W1996001880 @default.
• W85679339 cites W2002745358 @default.
• W85679339 cites W2003628336 @default.
• W85679339 cites W2008091740 @default.
• W85679339 cites W2015219342 @default.
• W85679339 cites W2021218223 @default.
• W85679339 cites W2022189167 @default.
• W85679339 cites W2050200979 @default.
• W85679339 cites W2057367943 @default.
• W85679339 cites W2060271381 @default.
• W85679339 cites W2064342451 @default.
• W85679339 cites W2071787763 @default.
• W85679339 cites W2075129349 @default.
• W85679339 cites W2087224363 @default.
• W85679339 cites W2096395306 @default.
• W85679339 cites W2107705298 @default.
• W85679339 cites W2134962084 @default.
• W85679339 cites W2151461824 @default.
• W85679339 cites W2376219091 @default.
• W85679339 cites W42210556 @default.
• W85679339 cites W42912816 @default.
• W85679339 cites W46054612 @default.
• W85679339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10967071" @default.
• W85679339 hasPublicationYear "2000" @default.
• W85679339 type Work @default.
• W85679339 sameAs 85679339 @default.
• W85679339 citedByCount "29" @default.
• W85679339 countsByYear W856793392012 @default.
• W85679339 countsByYear W856793392013 @default.
• W85679339 countsByYear W856793392014 @default.
• W85679339 countsByYear W856793392015 @default.
• W85679339 countsByYear W856793392021 @default.
• W85679339 crossrefType "journal-article" @default.
• W85679339 hasAuthorship W85679339A5071301207 @default.
• W85679339 hasAuthorship W85679339A5084984241 @default.
• W85679339 hasAuthorship W85679339A5087393717 @default.
• W85679339 hasConcept C101544691 @default.
• W85679339 hasConcept C104317684 @default.
• W85679339 hasConcept C143065580 @default.
• W85679339 hasConcept C153911025 @default.
• W85679339 hasConcept C16318435 @default.
• W85679339 hasConcept C170493617 @default.
• W85679339 hasConcept C176944494 @default.
• W85679339 hasConcept C180361614 @default.
• W85679339 hasConcept C207583985 @default.
• W85679339 hasConcept C26375932 @default.
• W85679339 hasConcept C2775960820 @default.
• W85679339 hasConcept C2781294074 @default.
• W85679339 hasConcept C42362537 @default.
• W85679339 hasConcept C54355233 @default.
• W85679339 hasConcept C62112901 @default.
• W85679339 hasConcept C62478195 @default.
• W85679339 hasConcept C86803240 @default.
• W85679339 hasConcept C95444343 @default.
• W85679339 hasConceptScore W85679339C101544691 @default.
• W85679339 hasConceptScore W85679339C104317684 @default.
• W85679339 hasConceptScore W85679339C143065580 @default.
• W85679339 hasConceptScore W85679339C153911025 @default.
• W85679339 hasConceptScore W85679339C16318435 @default.
• W85679339 hasConceptScore W85679339C170493617 @default.
• W85679339 hasConceptScore W85679339C176944494 @default.
• W85679339 hasConceptScore W85679339C180361614 @default.
• W85679339 hasConceptScore W85679339C207583985 @default.
• W85679339 hasConceptScore W85679339C26375932 @default.
• W85679339 hasConceptScore W85679339C2775960820 @default.
• W85679339 hasConceptScore W85679339C2781294074 @default.
• W85679339 hasConceptScore W85679339C42362537 @default.
• W85679339 hasConceptScore W85679339C54355233 @default.
• W85679339 hasConceptScore W85679339C62112901 @default.
• W85679339 hasConceptScore W85679339C62478195 @default.
• W85679339 hasConceptScore W85679339C86803240 @default.
• W85679339 hasConceptScore W85679339C95444343 @default.

• next